NSE: MASTEK · BSE: 523704 · ISIN INE759A01021
Mastek Limited stock analysis
Mastek Limited ranks #1054 in the TickerSutra evidence-ranked universe with a score of 57/100 and 95% data confidence. The latest captured fundamentals show ROCE of 17.7%, quarterly sales growth of 7.7% and quarterly profit growth of 15.0%.Monitor only
INVESTMENT EVIDENCE
What supports—and challenges—the thesis
Evidence in favour
- Low debt/equity of 0.15×
- Strong CFO/EBITDA of 0.92×
- Institutional ownership is rising
- CWIP indicates an active capacity pipeline
- No promoter shares are reported as pledged
Risks and constraints
- No calculated threshold risk in the current snapshot.
Still unresolved: Related-party exposure · Broad media sentiment
FINANCIAL TRAJECTORY
Recent operating history
| Period | Revenue | Operating profit | Net profit | Operating margin |
|---|---|---|---|---|
| 2022 | ₹2,184cr | ₹463cr | ₹333cr | 21.0% |
| 2023 | ₹2,563cr | ₹456cr | ₹310cr | 18.0% |
| 2024 | ₹3,055cr | ₹509cr | ₹311cr | 17.0% |
| 2025 | ₹3,455cr | ₹546cr | ₹376cr | 16.0% |
| 2026 | ₹3,699cr | ₹586cr | ₹404cr | 16.0% |
| TTM | ₹3,769cr | ₹600cr | ₹418cr | 16.0% |
EXCHANGE EVENT TRIGGERS
Latest corporate disclosures
Mastek Limited has informed the Exchange about Schedule of meet
RoutineMastek Ltd - 523704 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · 25 Sept 2026Intimation of Schedule of Analyst / Institutional Investor Meet
RoutineUpdatesNSE · 25 Sept 2026Mastek Limited has informed the Exchange regarding Intimation of cancellation of Schedule of Analyst / Institutional Investor Meet scheduled to be held on September 25, 2026''.
RoutineMastek Ltd - 523704 - Announcement Under Regulation 30 (LODR) - Analyst / Investor Meet - CancellationBSE · 25 Sept 2026Intimation of Cancellation of Schedule of Analyst / Institutional Investor Meet scheduled to be held on September 25, 2026.
RoutineCopy of Newspaper PublicationNSE · 19 Sept 2026Mastek Limited has informed the Exchange about Copy of Newspaper Publication regarding proposed transfer of shares to IEPF Authority
MANAGEMENT COMMENTARY
Signals from filed documents
So, we had some provision for doubtful impact during the quarter. We had certain mix change as well as some regulatory costs in the U.K., which got offset by the cost efficiency as well as the currency tailwind, which we had in the quarter. Sushovon: My only submission here is with this new cost, which is going to come on account of ESOP, what do you think will be the steady state EBITDA and EBIT margin for the compa
HOW TO READ THIS PAGE
Evidence, freshness and limitations
What does the TickerSutra score mean?
The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.
Which sources support this page?
Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.
Why can an item be unresolved?
Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.
Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer
DIRECTOR & BUSINESS NETWORK
Loading corporate intelligence
Loading universe coverage and exchange-backed evidence…